Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PLYX

Polaryx Therapeutics Inc

May 29 • 04:00PM ET

3.27

+0.22 7.21 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: KPTI CAMP CNTN CNTX IFRX RNA TLSA UNCY MGNX TENX

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.14	Insider Own	91.81%	Shs Outstand	47.34M	Perf Week	-17.01%
Market Cap	154.80M	Forward P/E	-	EPS next Y	-0.28	Insider Trans	0.21%	Shs Float	3.88M	Perf Month	-37.36%
Enterprise Value	151.72M	PEG	-	EPS next Q	-0.02	Inst Own	4.79%	Short Float	4.64%	Perf Quarter	7.21%
Income	-6.48M	P/S	-	EPS this Y	40.00%	Inst Trans	54.37%	Short Ratio	0.19	Perf Half Y	-
Sales	0.00M	P/B	62.23	EPS next Y	-133.33%	ROA	-163.15%	Short Interest	0.18M	Perf YTD	-90.66%
Book/sh	0.05	P/C	50.26	EPS next 5Y	-	ROE	-192.17%	52W High	48.91 -93.31%	Perf Year	-
Cash/sh	0.07	P/FCF	-	EPS past 3/5Y	-54.22% -	ROIC	-260.33%	52W Low	2.07 57.97%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	31.09% 20.95%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	16.88%	Oper. Margin	-	ATR (14)	0.74	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.45	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.19	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.45	EPS Q/Q	49.48%	SMA20	-6.68%	Beta	-	Target Price	10.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-34.62%	Rel Volume	0.60	Prev Close	3.05
Employees	11	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-41.35%	Avg Volume	934.55K	Price	3.27
IPO	Feb 02, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	563,362	Change	7.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)